Cancer Statistics, 2007, CA: A Cancer Journal for Clinicians, vol.57, issue.1, pp.43-66, 2007. ,
DOI : 10.3322/canjclin.57.1.43
Effects of hospital volume on life expectancy after selected cancer operations in older adults: a decision analysis, Journal of the American College of Surgeons, vol.196, issue.3, pp.410-417, 2003. ,
DOI : 10.1016/S1072-7515(02)01753-2
Neoadjuvant and adjuvant strategies for pancreatic cancer, European Journal of Surgical Oncology (EJSO), vol.34, issue.3, pp.297-305, 2007. ,
DOI : 10.1016/j.ejso.2007.07.204
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial., Journal of Clinical Oncology, vol.15, issue.6, pp.2403-2416, 1997. ,
DOI : 10.1200/JCO.1997.15.6.2403
Pharmacogenetics of anticancer drug sensitivity in pancreatic cancer, Molecular Cancer Therapeutics, vol.5, issue.6, pp.1387-95, 2006. ,
DOI : 10.1158/1535-7163.MCT-06-0004
A phase I/ II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma, Clin Cancer Res, vol.9, pp.555-61, 2003. ,
Antineoplasic activity of parvoviruses, Journal of Virological Methods, vol.33, issue.3, pp.233-51, 1991. ,
DOI : 10.1016/0166-0934(91)90024-T
The Autonomously Replicating Parvoviruses of Vertebrates, Adv Virus Res, vol.33, pp.91-174, 1987. ,
DOI : 10.1016/S0065-3527(08)60317-6
Highly Efficient Transduction and Expression of Cytokine Genes in Human Tumor Cells by Means of Autonomous Parvovirus Vectors; Generation of Antitumor Responses in Recipient Mice, Human Gene Therapy, vol.11, issue.4, pp.597-609, 2000. ,
DOI : 10.1089/10430340050015789
Transformation-dependent expression of interleukin genes delivered by a recombinant parvovirus, J Virol, vol.66, pp.2821-2829, 1992. ,
Potentiation of a recombinant oncolytic parvovirus by expression of Apoptin, Cancer Gene Therapy, vol.8, issue.12, pp.958-65, 2001. ,
DOI : 10.1038/sj.cgt.7700392
Cytosolic Activation of Cathepsins Mediates Parvovirus H-1-Induced Killing of Cisplatin and TRAIL-Resistant Glioma Cells, Journal of Virology, vol.81, issue.8, pp.4186-98, 2007. ,
DOI : 10.1128/JVI.02601-06
Experimental pancreatic cancer in the rat treated by photodynamic therapy, British Journal of Surgery, vol.4, issue.8, pp.1185-1194, 1994. ,
DOI : 10.1002/bjs.1800810835
Chimeric and Pseudotyped Parvoviruses Minimize the Contamination of Recombinant Stocks with Replication-Competent Viruses and Identify a DNA Sequence That Restricts Parvovirus H-1 in Mouse Cells, Journal of Virology, vol.77, issue.6, pp.3851-3859, 2003. ,
DOI : 10.1128/JVI.77.6.3851-3858.2003
Suppression of metastatic hemangiosarcoma by a parvovirus MVMp vector transducing the IP-10 chemokine into immunocompetent mice, Cancer Gene Therapy, vol.9, issue.5, pp.432-474, 2002. ,
DOI : 10.1038/sj.cgt.7700457
Expression of Multidrug Resistance Proteins in Rat and Human Chronic Pancreatitis, Pancreas, vol.28, issue.1, pp.45-52, 2004. ,
DOI : 10.1097/00006676-200401000-00007
Increased tumor growth and spread after laparoscopy vs laparotomy, Surgical Endoscopy, vol.13, issue.4, pp.365-70, 1999. ,
DOI : 10.1007/s004649900991
Upregulation of GADD34 mediates the synergistic anticancer activity of mitomycin C and a gamma134.5 deleted oncolytic herpes virus (G207), FASEB J, vol.18, pp.1001-1004, 2004. ,
Carrier cell-mediated delivery of oncolytic parvoviruses for targeting metastases, International Journal of Cancer, vol.5, issue.5, pp.742-751, 2004. ,
DOI : 10.1002/ijc.20013
Acquired Resistance of Pancreatic Cancer Cells towards 5-Fluorouracil and Gemcitabine Is Associated with Altered Expression of Apoptosis-Regulating Genes, Oncology, vol.62, issue.4, pp.354-62, 2002. ,
DOI : 10.1159/000065068
Suitability of a US3-inactivated HSV mutant (L1BR1) as an oncolytic virus for pancreatic cancer therapy, Cancer Gene Therapy, vol.148, issue.6, pp.533-575, 2007. ,
DOI : 10.1038/sj.cgt.7701049
Replication-competent Adenovirus-mediated Suicide Gene Therapy with Radiation in a Preclinical Model of Pancreatic Cancer, Molecular Therapy, vol.15, issue.9, pp.1600-1606, 2007. ,
DOI : 10.1038/sj.mt.6300212
5-Fluorouracil or gemcitabine combined with adenoviral-mediated reintroduction of p16INK4A greatly enhanced cytotoxicity in Panc-1 pancreatic adenocarcinoma cells, The Journal of Gene Medicine, vol.6, issue.5, pp.514-539, 2004. ,
DOI : 10.1002/jgm.540
Immunotherapeutic potential of oncolytic virotherapy, The Lancet Oncology, vol.9, issue.7, pp.610-612, 2008. ,
DOI : 10.1016/S1470-2045(08)70163-3
Combined oncolytic and vaccination activities of parvovirus H-1 in a metastatic tumor model, Oncology Reports, vol.17, pp.1493-1502, 2007. ,
DOI : 10.3892/or.17.6.1493
Effect of gemcitabine on immune cells in subjects with adenocarcinoma of the pancreas, Cancer Immunology, Immunotherapy, vol.45, issue.9, pp.915-940, 2005. ,
DOI : 10.1007/s00262-004-0638-1
Gemcitabine exerts a selective effect on the humoral immune response: implications for combination chemo-immunotherapy, Cancer Res, vol.62, pp.2353-2361, 2002. ,